浅谈慢性血液透析治疗的表面改性膜的生物相容性

杨 巩1, 王 志伟2
1、新疆医科大学第一附属医院重症医学科
2、青海省第五人民医院重症医学科

摘要


血液透析是全世界数百万人的维持生命的疗法。血液透析器中包含的膜无疑是血液透析治疗成功与否和质量的主要决定因素。膜特性影响溶质去除以及与血液成分的相互作用，从而定义膜的生物相容性。生物不相容性被认为是多种尿毒症并发症的潜在原因。因此，开发用作血液透析器膜的更具生物相容性的聚合物对于改善结果和临床患者预后至关重要。近年来，通过不同的方法制造了许多不同的用于血液透析的表面改性膜，以尽量减少血液不相容性。本文综述了它们在血液透析患者中的主要特征与结果。

关键词


生物相容性；凝 血；血液透析；膜；血小板

全文:

PDF


参考


[1]Wang Y N, Zhang Z H, Liu H J, et al. Integrative phosphatidylcholine metabolism through phospholipase A(2) in rats with chronic kidney disease [J]. Acta Pharmacol Sin, 2023, 44(2): 393-405.

[2]Ren L L, Miao H, Wang Y N, et al. TGF-β as A Master Regulator of Aging-Associated Tissue Fibrosis [J]. Aging Dis, 2023, 14(5): 1633-1650.

[3]Canaud B, Stephens M P, Nikam M, et al. Multitargeted interventions to reduce dialysis-induced systemic stress [J]. Clin Kidney J, 2021, 14(Suppl 4): i72-i84.

[4]Canaud B, Stephens M P, Nikam M, et al. Multitargeted interventions to reduce dialysis-induced systemic stress [J]. Clin Kidney J, 2021,14(Suppl 4): i72-i84.

[5]Bangsgaard K O,Andersen M,Heaf J G,Ottesen J T.Bayesian parameter estimation for phosphate dynamics during hemodialysis [J]. Math Biosci Eng, 2023,20(3):4455-4492.

[6]Vega-Vega O, Ronco C,Martínez-Rueda A J.Pushing the boundaries of hemodialysis:innovations in membranes and sorbents [J].Rev Invest Clin,2023,75(6): 274-288.

[7]Canaud B, Kooman J P, Selby N M, et al. Hidden risks associated with conventional short intermittent hemodialysis: A call for action to mitigate cardiovascular risk and morbidity [J]. World J Nephrol, 2022,11(2): 39-57.

[8]Gomółka M, Niemczyk L, Szamotulska K, et al.Biocompatibility of Hemodialysis [J].Advances in experimental medicine and biology, 2020,1251:91-97.

[9]Yu S, Yang H, Chen W, et al.Middle-size molecule clearance as measured by β2-microglobulin in high-flux versus low-flux dialysis and hemodiafiltration: A prospective randomized controlled trial [J]. Artif Organs,2023,47(1): 38-46.

[10]Díaz-Flores L,Gutiérrez R, García M P, et al. Comparison of the Behavior of Perivascular Cells (Pericytes and CD34+ Stromal Cell/Telocytes) in Sprouting and Intussusceptive Angiogenesis [J].Int J Mol Sci,2022, 23(16).

[11]Díaz-Flores L, Gutiérrez R, González-Gómez M, et al.Delimiting CD34+ Stromal Cells/Telocytes Are Resident Mesenchymal Cells That Participate in Neovessel Formation in Skin Kaposi Sarcoma [J].Int J Mol Sci, 2023,24(4).


Refbacks

  • 当前没有refback。